M. Marien et al., NORADRENALINE DEPLETION EXACERBATES MPTP-INDUCED STRIATAL DOPAMINE LOSS IN MICE, European journal of pharmacology, 236(3), 1993, pp. 487-489
Injection of C57Bl/6 mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyr
idine (MPTP; 4 X 10 mg/kg i.p. over 8 h) resulted in a partial (40%) s
triatal dopamine depletion at 7 days post-drug. Pretreatment with the
selective noradrenergic neurotoxin N-[2-chloroethyl]-N-ethyl-2-bromobe
nzylamine (DSP-4; 40 mg/kg i.p.), while having no effect per se on str
iatal dopamine levels, exacerbated the MPTP-induced dopamine deficit t
o 60%. Results support the hypothesis that damage to the locus coerule
us-noradrenergic system, by removing a facilitatory influence on the n
igrostriatal dopamine system, interferes with the ability of the nigro
striatal pathway to compensate for or recover from injury.